Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports
Elouni, B.; Ben Salem, C.; Zamy, M.; Ganne, N.; Beaugrand, M.; Bouraoui, K.; Biour, M.
Annals of PharmacoTherapy 44(12): 2035-2037
2010
ISSN/ISBN: 1060-0280 PMID: 21119102 DOI: 10.1345/aph.1p201Document Number: 215207
Document emailed within 0-6 h
Related Documents
Burness, C.B. 2015: Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): a Review of its use as an Oral Contraceptive Drugs 75(9): 1019-1026Sabo, J.P.; Lang, B.; Elgadi, M.; Huang, F. 2015: Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers Antimicrobial Agents and ChemoTherapy 59(1): 514-519
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Kapitza, C.; Nosek, L.; Jensen, L.; Hartvig, H.; Jensen, C.B.; Flint, A. 2015: Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel Journal of Clinical Pharmacology 55(5): 497-504
Edelman, A.; Munar, M.; Elman, M.R.; Koop, D.; Cherala, G. 2012: Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women British Journal of Clinical Pharmacology 74(3): 510-514
Cawello, W.; Rosenkranz, B.; Schmid, B.; Wierich, W. 2013: Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Epilepsia 54(3): 530-536
Ågren, U.M.; Anttila, M.; Mäenpää-Liukko, K.; Rantala, M.-L.; Rautiainen, H.; Sommer, W.F.; Mommers, E. 2011: Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 458-467
Hite, R.C.; Bannemerschult, R.; Fox-Kuchenbecker, P.; Turck, R.; Brill, K. 1999: Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 4(1): 7-13
Shibasaki, H.; Kuroiwa, M.; Uchikura, S.; Tsuboyama, S.; Yokokawa, A.; Kume, M.; Furuta, T. 2014: Use of endogenous cortisol 6β-hydroxylation clearance for phenotyping in vivo CYP3A activity in women after sequential administration of an oral contraceptive (OC) containing ethinylestradiol and levonorgestrel as weak CYP3A inhibitors Steroids 87: 137-144
Tantbirojn, P.; Taneepanichskul, S. 2002: Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women Contraception 66(6): 401-405
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443
Sanam, M.; Ziba, O. 2011: Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. which one has better affect on acne, hirsutism, and weight change Saudi Medical Journal 32(1): 23-26
Omsjø, I.H.; Oian, P.; Maltau, J.M.; Osterud, B. 1989: Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis Acta Obstetricia et Gynecologica Scandinavica 68(1): 27-30
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Wiesinger, H.; Eydeler, U.; Richard, F.; Trummer, D.; Blode, H.; Rohde, B.; Diefenbach, K. 2012: Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone Clinical Drug Investigation 32(10): 673-684
Woods, E.R.; Grace, E.; Havens, K.K.; Merola, J.L.; Emans, S.J. 1992: Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients American Journal of Obstetrics and Gynecology 166(3): 901-907
Zimmerman, Y.; Coelingh Bennink, H.J.T.; Wouters, W.; Ebes, F.; Fauser, B.C.J.M. 2013: The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(6): 489-500
Bilotta, P.; Favilli, S. 1988: Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive Arzneimittel-Forschung 38(7): 932-934
Archer, D.F.; Maheux, R.; DelConte, A.; O'Brien, F.B. 1999: Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG) American Journal of Obstetrics and Gynecology 181(5 Pt 2): 39-44
1987: Clinical studies with a new, low-dose oral contraceptive combination, containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol Acta obstetricia et gynecologica Scandinavica. Supplement 144: 1-44